Skadden Reps JLL Partners In $115M Health Buy-And-Build

Law360, New York (February 12, 2013, 5:13 PM EST) -- Private equity firm JLL Partners on Tuesday commenced a tender offer for BioClinica Inc. that values the manager of clinical trials at about $115 million and will allow it to be merged with another recently acquired health care company.

JLL Partners, a New York-based private equity firm with about $4 billion of capital and a focus on healthcare and pharma deals, will pay Pennsylvania-based BioClinica stockholders $7.25 per share. The tender offer follows a merger agreement signed Jan. 30.

JLL is also acquiring CoreLab Partners Inc., a...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.